Optimising symptom management in children with cancer using a novel mobile phone applicatio

Not Applicable

Recruiting

• Conditions: Cancer; Psychological symptoms related to cancer treatment including: worry, sadness, anger and anxiety; Chemotherapy related problems with thinking, remembering or concentration; Body image concerns related to cancer treatment (e.g. hair loss, scars, amputation); Fatigue; Chemotherapy induced mucositis; Headache related to cancer or cancer treatment; Pain related cancer or cancer treatment; Chemotherapy induce peripheral neuropathy; Chemotherapy induced nausea or vomiting

• Registration Number: ACTRN12621001084875
• Lead Sponsor: Queensland University of Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-08-16
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 192

Inclusion Criteria

Children aged 2-18 years, receiving active treatment for blood cancer or solid tumors and their caregiver/s aged 18 years and over are included. Active treatment for cancer is defined as receiving either planned cycles of chemotherapy or radiotherapy. Participants will be recruited within two weeks of a planned treatment cycle. Prior to recruitment, their clinical status and the appropriateness to approach potential participants will be confirmed with the treating clinicians. Participants are required to be able to read and understand English, and to have access to a smartphone, iPad or computer and Internet

Exclusion Criteria

Children with brain cancer are excluded from this study due to multiple competing studies currently being undertaken in children’s brain cancer at the cancer centre and the concern of overburdening participants. Furthermore, participants will be excluded if there is difficulty with obtaining consent (e.g. the child is under child protection orders), or if there are difficulties understanding English

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome is total symptom burden measured weekly by the SSPedi. [Week 1, Week 2, Week 3, Week 4, Week 5, Week 6, Week 7, Week 8]

Secondary Outcome Measures

Name	Time	Method
Health-related quality-of-life (PedsQL Cancer Module) [Baseline, Week 1, Week 4, Week 8];Pain (FACES pain scale)[Week 1, Week 4, Week 8];Complications during study period will be collected from medical records [Follow up at end of study];Distress (Paediatric Distress thermometer)[Week 1, Week 2, Week 3, Week 4, Week 5, Week 6, Week 7, Week 8];Self-efficacy (Brief Resilient Coping Scale)<br><br>The tool will be used in the intervention group only. [Baseline, Week 4, week 8]